Clinical trial
Combination Chemotherapy in Treating Patients With Liver Metastases From…
NCT00002716 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002716 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer |
| Official title | PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | dexamethasone, floxuridine, fluorouracil, leucovorin calcium, laparotomy, conventional surgery |
| Enrollment | 135 |
| Start date | Jan 1, 1996 |
| Primary completion | Mar 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | Australia, Peru, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: